Navigation Links
More than Morning Sickness: Kate Middleton's Pregnancy Announcement Draws Attention to Rare Pregnancy Condition Known as Hyperemesis Gravidarum (HG)
Date:12/3/2012

LEESBURG, Va., Dec. 3, 2012 /PRNewswire-iReach/ -- The announcement that Kate Middleton is expecting her first child is bringing attention to a little-known pregnancy condition known as hyperemesis gravidarum (HG), a severe form of nausea and vomiting in pregnancy that can be debilitating because it causes serious dehydration and malnutrition. The condition is often misunderstood, even by healthcare professionals.

HG is generally marked by unrelenting nausea and vomiting that prevents women from eating or drinking and unable to keep anything down for months. Pregnant women who suffer from HG often lose weight during pregnancy and have difficulty carrying on daily activities. Those with the most severe symptoms are often hospitalized or placed on intravenous feeding.

"The HER Foundation sends their thoughts and prayers to Duchess Kate. We hope she knows she has tens of thousands of women around the world who understand what HG is and how it makes you feel physically and emotionally," said Ann Marie King, co-founder of the foundation, the world's largest grassroots network of HG survivors/supporters and leading site for HG information on the Internet. "Only those who have experienced HG can truly understand it. HG is so much more than morning sickness and its effects can be life changing."

It's estimated up to 2 percent of pregnant women in the U.S. are diagnosed with HG, the HER Foundation believes it is closer to 10 percent just by the pure volume of visits they receive on their site. Unfortunately, HG is not fully understood and a cause is not known. New theories and findings emerge every year, substantiating that it is a complex physiological disease likely caused by multiple factors.

Recent, conservative estimations suggest HG costs nearly $200 million annually just for inpatient hospitalization. Considering many women are treated outside the hospital to save costs, the actual cost is likely many times greater.

Dr. Marlena Fejzo, who has been heading up the research for HG at UCLA says, "I hope that Duchess Middleton is getting proper support and care including a thiamine shot if she is unable to tolerate vitamins to prevent a severe but completely avoidable HG-related condition, Wernicke's Encephalopathy.  I also hope the suffering of Duchess Middleton leads to more awareness, funding, and participation in research for this devastating and misunderstood pregnancy disease so that scientists like myself, can find answers.  My research focuses on identification of genes and risk factors for HG to identify the cause and cure and working with the HER Foundation."

Diagnosis is usually made by measuring weight loss, checking for ketones, and assessing the overall condition of the mother. Early intervention is critical.  Severe vomiting and nausea alone can cause complications including debilitating fatigue, gastric irritation, ketosis and malnutrition. Aggressive care early in pregnancy is very important to prevent these and more life-threatening complications.

"We can only hope that this amount of awareness will truly help educate the public, media and the medical profession about HG. We also hope through this awareness HG will finally receive the research funding it so desperately needs. HG is so much more than just morning sickness, it is a debilitating condition of pregnancy that needs to be taken seriously" King said.

For more information, visit the HER Foundation website at www.helpher.org or www.facebook.com/HERFoundation

Media Contact: Anne Marie King HER Foundation, 703-399-1272, annmarie@helpher.org

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE HER Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Brand new Solid Form Co-Crystals and Amorphous Focus Morning at the Pharmaceutical Co-Crystals and Amorphous Material 2012 Summits
2. Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD
3. Landauer, Inc. Sets Date And Time For Announcement Of Fiscal Fourth Quarter And Full Year 2012 Results
4. Omeros Responds to Misleading Announcement by Davis Wright Tremaine Concerning Settlement with Former Chief Financial Officer
5. Precyse Open Letter on ICD-10 Final Announcement
6. VirtualScopics Schedules Second Quarter 2012 Earnings Announcement
7. Lilly Confirms Date and Conference Call for Second-Quarter 2012 Financial Results Announcement
8. Purdue Pharma L.P. Comments on FDA Announcement on REMS for Extended-Release and Long-Acting Opioid Analgesics
9. New company announcement: TERGUS PHARMA
10. Gen-Probe Withdraws from Previously Announced Investor Presentations
11. Attention Veterans: New Medtech Job Training Program Accepting Applications through Friday, August 31
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2017)... AirXpanders, Inc. (ASX: AXP) (AirXpanders or Company), ... sale and distribution of the AeroForm® Tissue Expander System, ... commercial roll-out in the United States ... hundred (100) medical institutions and health systems, located throughout ... alternative for women who choose reconstructive surgery following a ...
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly ... announced that results from the Phase 3 MONARCH ... (CDK)4 & 6 inhibitor, in combination with fulvestrant, ... with fulvestrant alone in women with hormone-receptor-positive (HR+), ... breast cancer who have relapsed or progressed after ...
Breaking Medicine Technology:
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... Guide to ... , No matter on which side of the Atlantic devicemakers do business, ... regulations they have to follow. , In addition to the full text of the ...
(Date:6/28/2017)... ... June 28, 2017 , ... The Wharton School’s ... mid-market executives as a kick-off to the fifth annual CEO Connection Mid-Market Convention. ... the University of Pennsylvania campus, followed by the two-day convention, which will target ...
(Date:6/28/2017)... ... June 28, 2017 , ... Doner Financial, ... regions access to insurance assistance and financial planning services, is announcing the commencement ... families in the region facing financial crisis. , Matthew 25: Ministries (M25M) is ...
(Date:6/27/2017)... ... June 27, 2017 , ... DrugDev understands that ... they can trust the sponsor to pay them correctly and on time. As the ... establish payment strategies that encourage sites to work on their studies. , At a ...
(Date:6/27/2017)... , ... June 27, 2017 , ... From June 20-22, ... three-day event was held in Syracuse, New York, where EarQ is headquartered. , ... how to connect with today’s savvy consumer, and the latest in hearing technology. ...
Breaking Medicine News(10 mins):